showed that a combination of intratumoral CDN together with the IL‐2 superkine H9‐MSA induced strong systemic activation of NK cells.[40] They demonstrated that CD8+ T cells, but not NK cells, were required for MHC‐I+ tumor elimination. This evidence concerns the gene CD8A and neoplasm.